Usmani, S Z
Zhang, Q
Stratton, K
Qu, P
Yaccoby, S
Hansen, E
Steward, D
Panozzo, S
Petty, N
Hoering, A
Waheed, S
Van Rhee, F
Crowley, J
Barlogie, B
Article History
First Online: 25 August 2014
Competing interests
: SZU is a consultant to Celgene, Millennium, Onyx and Sanofi. He has received research funding from ArrayBioPharma, Celgene, Onyx, Janssen, Pharmacyclics, and speaking honoraria from Celgene, Millennium and Onyx. BB has received research funding from Celgene and Novartis. He is a consultant to Celgene and Genzyme and has received speaking honoraria from Celgene and Millennium. BB is a co-inventor on patents and patent applications related to use of GEP in cancer medicine.